• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

    1.170 +0.030 (+2.63%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 201,288
    Open 1.120
    Bid (Size) 1.120 (20,000)
    Ask (Size) 1.190 (2,200)
    Prev. Close 1.140
    Today's Range 1.111 - 1.195
    52wk Range 0.9174 - 8.940
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Medicus Pharma on Bloomberg World
    Via ACCESS Newswire
    News headline image
    New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.
    Via ACCESS Newswire

    Performance

    YTD
    -26.9%
    -26.9%
    1 Month
    -4.9%
    -4.9%
    3 Month
    -40.9%
    -40.9%
    6 Month
    -46.1%
    -46.1%
    1 Year
    -69.3%
    -69.3%

    More News

    Read More
    News headline image
    Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
    Via ACCESS Newswire
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers
    From Medicus Pharma Ltd.
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    From Medicus Pharma
    Via GlobeNewswire
    News headline image
    Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    Via ACCESS Newswire
    Medicus Pharma Ltd. (NASDAQ: MDCX) and the Patch That Could End Repetitive Cancer Surgeries
    Via AB Newswire
    Emerging Biotech Stars Poised for Multi-Billion-Dollar Breakthroughs (MDCX, ACTU, LTRN, TNXP)
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
    From Medicus Pharma
    Via GlobeNewswire
    4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)
    Via AB Newswire
    News headline image
    Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
    Via ACCESS Newswire
    4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH)
    Via AB Newswire

    Frequently Asked Questions

    Is Medicus Pharma Ltd. - Common Stock publicly traded?
    Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
    What exchange does Medicus Pharma Ltd. - Common Stock trade on?
    Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
    The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
    What is the current price of Medicus Pharma Ltd. - Common Stock?
    The current price of Medicus Pharma Ltd. - Common Stock is 1.170
    When was Medicus Pharma Ltd. - Common Stock last traded?
    The last trade of Medicus Pharma Ltd. - Common Stock was at 02/24/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.